US STOCK
DXCM Stock Analysis
US stocks · market data · technical indicators
DexCom, Inc.
DXCMUS stocksQuote delayed 15 min
10/27 上午06:15 updated
$78.57
+0.63+0.81%
Open
$77.25
High
$78.58
Low
$76.52
Volume
625.00萬
DXCM price history
-9.36%Open
86.68
Latest
78.57
High
87.71
Low
77.94
Average
84.25
Advertisement
Financial snapshot
DXCM - DexCom, Inc.
EPS
2.52USD
Forward EPS
3.12USD
P/E
31.18x
Forward P/E
25.15x
P/B
11.31x
ROE
38.49%
ROA
10.33%
Operating margin
24.33%
Profit margin
20.12%
Revenue growth
13.10%
Earnings growth
43.60%
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B |
| Gross profit | $830.00M | $750.30M | $792.70M | $731.40M | $688.80M |
| Operating income | $318.30M | $255.30M | $323.00M | $242.50M | $212.60M |
| Net income | $249.10M | $199.50M | $267.30M | $283.80M | $179.80M |
| Basic EPS | 0.65 | 0.52 | 0.69 | 0.73 | 0.46 |
| Diluted EPS | 0.64 | 0.51 | 0.68 | 0.70 | 0.45 |
Estimates vs actuals
Next earnings
2026-10-29
EPS estimate
0.67
Revenue estimate
$1.33B
Last surprise
+15.11%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-29 | 0.67 | Not reported | — |
| 2026-07-30 | 0.61 | 0.70 | +15.11% |
| 2026-04-30 | 0.47 | 0.56 | +18.99% |
| 2026-02-12 | 0.65 | 0.68 | +4.50% |
| 2025-10-30 | 0.57 | 0.61 | +7.51% |
| 2025-07-30 | 0.44 | 0.48 | +8.25% |
| 2025-05-01 | 0.33 | 0.32 | -2.56% |
| 2025-02-13 | 0.50 | 0.45 | -9.87% |
| 2024-10-24 | 0.43 | 0.45 | +3.53% |
| 2024-07-25 | 0.39 | 0.43 | +11.36% |
| 2024-04-25 | 0.27 | 0.32 | +18.61% |
| 2024-02-08 | 0.43 | 0.50 | +16.01% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $3.9B | 0.09% |
| VANGUARD GROUP INC | 2025-12-31 | $3.3B | 0.05% |
| STATE STREET CORP | 2026-06-30 | $1.2B | 0.04% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $109.8M | 0.15% |
| CITADEL ADVISORS LLC | 2026-06-30 | $81.6M | 0.01% |
| Bridgewater Associates, LP | 2026-06-30 | $27M | 0.11% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $3.1M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$96.19
Target range
$79.00 – $115.00
Implied upside
22.43%
Strong buy
4
Buy
22
Hold
3
Sell
0
Strong sell
0
Advertisement